REPORT ID 13375

EMEA (Europe, Middle East and Africa) Blood Product Market Report 2017

Publish Date
21-Nov-17
Pages
105
Format
Electronic (PDF)

In this report, the EMEA Blood Product market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Blood Product for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Blood Product market competition by top manufacturers/players, with Blood Product sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Shire
    CSL
    Grifols
    Octapharma
    BPL
    Kedrion
    Mitsubishi Tanabe
    CBOP
    RAAS
    Hualan Bio

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Albumin
    Immune Globulin
    Coagulation Factor

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Blood Product for each application, including
    Immunity
    Therapy
    Surgery
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Blood Product Market Report 2017
1 Blood Product Overview
    1.1 Product Overview and Scope of Blood Product
    1.2 Classification of Blood Product
        1.2.1 EMEA Blood Product Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Blood Product Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Albumin
        1.2.4 Immune Globulin
        1.2.5 Coagulation Factor
    1.3 EMEA Blood Product Market by Application/End Users
        1.3.1 EMEA Blood Product Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Immunity
        1.3.3 Therapy
        1.3.4 Surgery
        1.3.5 Other
    1.4 EMEA Blood Product Market by Region
        1.4.1 EMEA Blood Product Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Blood Product (2012-2022)
        1.5.1 EMEA Blood Product Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Blood Product Revenue and Growth Rate (2012-2022)

2 EMEA Blood Product Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Blood Product Market Competition by Players/Manufacturers
        2.1.1 EMEA Blood Product Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Blood Product Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Blood Product Sale Price by Players (2012-2017)
    2.2 EMEA Blood Product (Volume and Value) by Type/Product Category
        2.2.1 EMEA Blood Product Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Blood Product Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Blood Product Sale Price by Type (2012-2017)
    2.3 EMEA Blood Product (Volume) by Application
    2.4 EMEA Blood Product (Volume and Value) by Region
        2.4.1 EMEA Blood Product Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Blood Product Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Blood Product Sales Price by Region (2012-2017)

3 Europe Blood Product (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Blood Product Sales and Value (2012-2017)
        3.1.1 Europe Blood Product Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Blood Product Revenue and Growth Rate (2012-2017)
    3.2 Europe Blood Product Sales and Market Share by Type
    3.3 Europe Blood Product Sales and Market Share by Application
    3.4 Europe Blood Product Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Blood Product Sales Volume by Countries (2012-2017)
        3.4.2 Europe Blood Product Revenue by Countries (2012-2017)
        3.4.3 Germany Blood Product Sales and Growth Rate (2012-2017)
        3.4.4 France Blood Product Sales and Growth Rate (2012-2017)
        3.4.5 UK Blood Product Sales and Growth Rate (2012-2017)
        3.4.6 Russia Blood Product Sales and Growth Rate (2012-2017)
        3.4.7 Italy Blood Product Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Blood Product Sales and Growth Rate (2012-2017)

4 Middle East Blood Product (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Blood Product Sales and Value (2012-2017)
        4.1.1 Middle East Blood Product Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Blood Product Revenue and Growth Rate (2012-2017)
    4.2 Middle East Blood Product Sales and Market Share by Type
    4.3 Middle East Blood Product Sales and Market Share by Application
    4.4 Middle East Blood Product Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Blood Product Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Blood Product Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Blood Product Sales and Growth Rate (2012-2017)
        4.4.4 Israel Blood Product Sales and Growth Rate (2012-2017)
        4.4.5 UAE Blood Product Sales and Growth Rate (2012-2017)
        4.4.6 Iran Blood Product Sales and Growth Rate (2012-2017)

5 Africa Blood Product (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Blood Product Sales and Value (2012-2017)
        5.1.1 Africa Blood Product Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Blood Product Revenue and Growth Rate (2012-2017)
    5.2 Africa Blood Product Sales and Market Share by Type
    5.3 Africa Blood Product Sales and Market Share by Application
    5.4 Africa Blood Product Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Blood Product Sales Volume by Countries (2012-2017)
        5.4.2 Africa Blood Product Revenue by Countries (2012-2017)
        5.4.3 South Africa Blood Product Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Blood Product Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Blood Product Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Blood Product Sales and Growth Rate (2012-2017)

6 EMEA Blood Product Manufacturers/Players Profiles and Sales Data
    6.1 Shire
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Blood Product Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Shire Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 CSL
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Blood Product Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 CSL Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Grifols
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Blood Product Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Grifols Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Octapharma
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Blood Product Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Octapharma Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 BPL
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Blood Product Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 BPL Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Kedrion
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Blood Product Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Kedrion Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Mitsubishi Tanabe
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Blood Product Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Mitsubishi Tanabe Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 CBOP
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Blood Product Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 CBOP Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 RAAS
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Blood Product Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 RAAS Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Hualan Bio
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Blood Product Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Hualan Bio Blood Product Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Blood Product Manufacturing Cost Analysis
    7.1 Blood Product Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Blood Product

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Blood Product Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Blood Product Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Blood Product Market Forecast (2017-2022)
    11.1 EMEA Blood Product Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Blood Product Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Blood Product Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Blood Product Price and Trend Forecast (2017-2022)
    11.2 EMEA Blood Product Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Blood Product Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Blood Product Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Blood Product Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Blood Product Sales Forecast by Type (2017-2022)
    11.7 EMEA Blood Product Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer